Electronics Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Electronics Press Releases.

Press releases published on September 1, 2026

Sep. 1, 2026

ElevateBio Appoints Steven Falcone as Chief Operating Officer

Indeterminate GlobeNewswire

Sep. 1, 2026

ROC Completes Acquisition of ZTC; Strengthening Competitive Position for ROC’s Vision AI Platform

Indeterminate GlobeNewswire

Sep. 1, 2026

Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

BioCryst to Present at Upcoming Investor Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Award-Winning BrewDog Unleashes Liquid Visions, a Bold New Craft Beer Series Built to Light Up Retail Shelves

Indeterminate GlobeNewswire

Sep. 1, 2026

Aben Gold Provides Drill Program Update at Justin Gold-Tungsten Project

Indeterminate GlobeNewswire

Sep. 1, 2026

Satellos to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral STAT6 Degrader, at the European Respiratory Society and European Academy of Dermatology & Venereology Congresses

Indeterminate GlobeNewswire

Sep. 1, 2026

Processa Pharmaceuticals to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

CW Petroleum Corp (OTCQB: CWPE) Reports Financial Results for the Six Months Ended June 30, 2026

Indeterminate GlobeNewswire

Sep. 1, 2026

Ocular Therapeutix™ to Participate in September and October Investor and Scientific Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

BlossomHill Therapeutics to Present Updated Data from Ongoing Phase 1/2 SOLARA Trial of its Macrocyclic OMNI-EGFR™ Inhibitor, BH-30643, in EGFR-mutant NSCLC at the 2026 World Conference on Lung Cancer

Indeterminate GlobeNewswire

Sep. 1, 2026

NOVONIX Selected for South Korea-U.S. Infrastructure Initiative

Indeterminate GlobeNewswire

Sep. 1, 2026

VR Releases AGM Results and Provides Update on Empire Transaction

Indeterminate GlobeNewswire

Sep. 1, 2026

Lightbridge Receives Notice of Allowance on New Japanese Patent Covering Multi-Zone Fuel Element and 3D Printing Method

Indeterminate GlobeNewswire

Sep. 1, 2026

Electra Strengthens Commercial Team with Appointment of Veteran Cobalt and Nickel Trader Douglas Geniti

Indeterminate GlobeNewswire

Sep. 1, 2026

Aya Gold & Silver to Acquire Copper-Silver Portfolio

Indeterminate GlobeNewswire

Sep. 1, 2026

Auddia Announces Influence Healthcare’s First Specialty Hospital LOI, Marking a Major Milestone in the Company’s Healthcare Expansion

Indeterminate GlobeNewswire